Hologic Genius AI vs Nanox.AI

Nanox.AI reads CT scans acquired for other reasons and looks for coronary calcium (HealthCCSng), vertebral height loss and bone density (HealthOST) and liver fat (HealthFLD). A 2025 Diagnostics validation of HealthOST reported 92.0% sensitivity for vertebral compression fractures at the 20% height-loss threshold, with specificity figures from 52.7% in the abstract. openFDA lists twelve AI records under the Zebra, Nanoxai and Nano-X AI names, while Nanox's AI page says seven FDA clearances and lists three current solutions. Hologic's Genius AI Detection gives each tomosynthesis exam a case score and, per its product page, a Reading Priority Indicator that flags about 8 to 10% of the most concerning cases. Nanox's AI page lists CT solutions for cardiac, bone and liver findings, bought by a radiology department running opportunistic screening on CTs it already has, while Hologic's product reads mammograms for a breast imaging service. The two do not compete for one purchase. openFDA also lists a 2020 mammography notification record, HealthMammo (K200905), under the Zebra name, and Nanox's AI page does not state whether it is still sold.